Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers

Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers

Her-2/neu is a tumor-associated protein that is overexpressed in a number of malignancies, including advanced cancer of the stomach, and has been proposed as a human cancer vaccine target. Overexpression of Her-2/neu in human breast and gastric carcinomas correlates with a more aggressive course of...

Full description

Bibliographic Details
Main Authors: Nicholas J. Ede, Anthony J. Good, Joshua Tobias, Erika Garner-Spitzer, Christoph C. Zielinski, Ursula Wiedermann
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
cancer vaccine
peptide
immunotherapy
HER-2
PD-1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.939356/full

Similar Items

Similar Items